Hans Hofstraat

Hans Hofstraat completed his thesis (Free University, Amsterdam; awarded by Royal Dutch Shell prize) and post-doctoral work (Eidgenössische Technische Hochschule, Zürich, Switzerland) on low-temperature high-resolution luminescence spectroscopy. Subsequently he turned to marine environmental research, in the laboratory of the Dutch Public Works Department in Rijswijk, The Netherlands. He then moved to industry, conducting research at Akzo Nobel Central Research in Arnhem, the Netherlands. From 1998-2008 he was part-time professor in the Institute of Molecular Chemistry at the University of Amsterdam. In 1998 he was appointed department head at Philips Research, Eindhoven (the Netherlands). In 2003 he was appointed Vice President Philips Research. In 2005 he became Sector Head Molecular Medicine in Philips Research Europe, and globally responsible for the Focal Area Molecular Medicine in Philips Research. Since 2007 he is responsible for Healthcare Strategic Partnerships in Philips Research worldwide, actively driving the Open Innovation approach to Philips’ Healthcare research program. Since 2009 he is Innovation Program Manager and member of the Program Board within Philips Research, focusing on various innovation topics across and adjacent to the Philips HealthTech portfolio.

Next to his work at Philips he holds several positions in (inter)national advisory bodies. Amongst others, he is member of the Dutch Sounding Board for Horizon 2020, Theme Health, Demographic Change and Well-being. He is Member of the Steering Committee and Co-Chair of the Taskforce Roadmap Homecare and Self-Management of the Topsector Life Sciences & Health, and Theme Coordinator of the Nanomedicine program in the Public-Private Partnership NanoNextNL. He is member of the Management Team of the Institute for Diagnostic and Interventional Imaging (IDII), in which Philips participates together with UMC Utrecht, University Utrecht, and TU Eindhoven. He is member of the Supervisory Board of the European Institute of Innovation & Technology Health, and member of the European Scientific Panel for Health.

Hofstraat authored over 190 publications with an h-index of 40 (Google Scholar). He holds 10 granted US patents, and a total of over 80 patent (application)s in various countries from 25 patent families in various fields.

 

back to program | back to plenary session